SEC Company Response from NOVADEL PHARMA INC (CIK 0001043873) — Jul 27, 2005

NOVADEL PHARMA INC (CIK 0001043873)
Date: July 27, 2005 · CIK: 0001043873 · Accession: 0001144204-05-022791

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-126489

Date

July 27, 2005

Author

Assistant Director

Form

CORRESP

Company

NOVADEL PHARMA INC (CIK 0001043873)

Letter

NOVADEL PHARMA INC. July 27, 2005 Mr. Jeffrey P. Riedler Assistant Director Securities and Exchange Commission Division of Corporate Finance Mail Stop 6010 Washington, D.C. 20549 NovaDel Pharma Inc. Registration Statement on Form S-3 (File No. 333-126489)

Dear Mr. Riedler:

NovaDel Pharma Inc., a Delaware corporation (the "Company"), hereby requests that the effectiveness of the Company's Registration Statement on Form S-3, SEC File No. 333-126489 (the "Filing"), for up to 9,426,234 shares of the Company's common stock, par value $0.001 per share, be accelerated to 5:00 p.m., July 27, 2005, or as soon thereafter as is practicable.

In connection with this letter, the Company acknowledges as follows:

o Should the Commission or the staff, acting pursuant to delegated authority, declare the Filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

o The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the Filing; and

o The company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very truly yours,
NOVADEL PHARMA INC.

Show Raw Text

<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
                  NOVADEL PHARMA INC.

                                                                   July 27, 2005

Mr. Jeffrey P. Riedler
Assistant Director
Securities and Exchange Commission
Division of Corporate Finance
Mail Stop 6010
Washington, D.C. 20549

                               NovaDel Pharma Inc.
                       Registration Statement on Form S-3
                              (File No. 333-126489)

Dear Mr. Riedler:

            NovaDel Pharma Inc., a Delaware corporation (the "Company"), hereby
requests that the effectiveness of the Company's Registration Statement on Form
S-3, SEC File No. 333-126489 (the "Filing"), for up to 9,426,234 shares of the
Company's common stock, par value $0.001 per share, be accelerated to 5:00 p.m.,
July 27, 2005, or as soon thereafter as is practicable.

            In connection with this letter, the Company acknowledges as follows:

            o     Should the Commission or the staff, acting pursuant to
                  delegated authority, declare the Filing effective, it does not
                  foreclose the Commission from taking any action with respect
                  to the filing;

            o     The action of the Commission or the staff, acting pursuant to
                  delegated authority, in declaring the Filing effective, does
                  not relieve the company from its full responsibility for the
                  adequacy and accuracy of the disclosure in the Filing; and

            o     The company may not assert this action as a defense in any
                  proceeding initiated by the Commission or any person under the
                  federal securities laws of the United States.

                                        Very truly yours,

                                        NOVADEL PHARMA INC.

                                        By: /s/ Jean W. Frydman
                                            -------------------------------
                                            Name:   Jean W. Frydman
                                            Title:  Vice President and General
                                                    Counsel
</TEXT>
</DOCUMENT>

SecProbe.io